Blemfree Salicylic Acid Lotion Recalled for Manufacturing Practice Deviations
Equibal Inc. is recalling Blemfree All Day Lotion due to manufacturing deviations from Current Good Manufacturing Practices. The product was distributed nationwide via internet sales.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for manufacturing practice deviations with no reported illnesses or injuries. The specific safety hazard is not identified in the source, making this a precautionary, compliance-based recall.
Plain-English summary
Equibal Inc. is recalling Blemfree All Day Lotion (salicylic acid 0.5%) due to manufacturing deviations from Current Good Manufacturing Practices (CGMP). The recall applies to specific lot numbers distributed nationwide in the United States via internet sales.
The recalled product is available in two package sizes: 1 oz. (29 mL) tubes and 4 oz. (118 mL) bottles. Affected lot numbers include BF063221 (tubes, expiration 03/04/2025) and BF097221 (both tubes and bottles, expiration 04/07/2025).
Consumers who have purchased this product should discontinue use. For information on returning affected products, contact Equibal Inc. or the FDA. This is an FDA Class II recall.
The recalled product
- Product
- BLEMFREE (SALICYLIC ACIDE)
- Brand
- BLEMFREE
- Manufacturer
- Equibal Inc
- Category
- Drug — Topical / Acne Treatment
- Hazard
- cgmp-violation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot # a) BF063221
- exp. date 03/04/2025
- BF097221
- exp. date 04/07/2025
- b) BF097221 exp date 04/07/2025
UPCs (1)
- 701450900086
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27